Muhammad Hamid Khan

研究方向：抗癌化合物的设计合成

在读期间发表论文：

1. Khan MH, Cai ML, Li SH, Zhang ZL, Zhang JZ, Wen XA, Sun HB*, Liang H, Yang F*. Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides. European Journal of Medicinal Chemistry, 2019, 182: 111616.

2. Khan MH, Cai ML, Deng JG, Yu P, Liang H*, Yang F*. Anticancer function and ROS-mediated multi-targeting anticancer mechanisms of copper (II) 2-hydroxy-1-naphthaldehyde complexes. Molecules. 2019, 24: 2544.

3. Li SH^#, Khan MH^#, Wang XJ^#, Cai ML, Zhang JZ, Jiang M, Zhang ZL, Wen XA, Liang H, Yang F*. Synthesis of a series of novel In(III) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism. Dalton Transactions, 2020, 49: 17207−17220.

学习经历：

2015/09-2019/12，广西师范大学化学与药学学院(博士)

毕业去向：

毕业后回巴基斯坦工作

邮箱：hamidbayer@hotmail.co.uk